Please assess the completion status of the following clinical trial:

Trial Title: Metacognitive Training to Enhance Strategy Use in Blast-Related TBI

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* 2 incidences of blast-related mTBI according to the American Congress of Rehabilitation Medicine, any of three following criteria:~  * loss of consciousness \<30 minutes, a Glasgow Coma Scale of 13~ * loss of memory for events immediately before and after the event (24 hours alteration of mental state at the time of accident)~ * focal neurological deficits that may, or may not, be transient (ACRM, 1993)~* Diagnosis must be documented in the medical record by a physician or neuropsychologist.~* Frontal Lobe impairment will be determined by 1.5 standard deviations below the mean on either the D-KEFS Color Word Interference Testorthe EXAMINER composite score.~* Age 18 to 55 years.~* At least 6 months post injury.~* Family member or friend that is willing to answer questionnaires and provide feedback on questionnaires and completion of homework.~Exclusion Criteria:~* History of pre-morbid learning disability.~* History of psychiatric diagnosis sufficiently severe to have resulted in inpatient hospitalization.~* Neurological disease unrelated to TBI (seizure disorder, stroke, ADHD).~* Score \< 90 on National Adult Reading Test.~* Failure of validity testing on the Test of Memory Malingering (TOMM)~* Reported alcohol or substance abuse within the past year, or such abuse documented in medical record.~* Reported involvement in current litigation.~* Changes within the past month of medications known to affect cognitive functions e.g. benzodiazepines, opioids, antidepressants and antipsychotics.~* Currently enrolled in other cognitive therapy that cannot be discontinued.~* Not fluent in English.~* Not competent to provide consent (also, not able to demonstrate understanding of expectations of study and potential risks of participation).~* Patients who receive \> 5 hours of therapy from a mental health specialist during the study will not be included in the final analysis.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 55 Years
- Healthy Volunteers: f

Study Arms:
- Arm 1: Treatment Goal Management Training (Type: EXPERIMENTAL): Treatment Goal Management Training
- Arm 2: Control-Brain Health Workshop (Type: NO_INTERVENTION): Control-Brain Health Workshop

Based on this trial design, predict the completion outcome and termination type (if applicable).